Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
Browsing: HIV/AIDS
Marijuana use among pregnant and postpartum individuals living with HIV increased from 2007 to 2019, according to a Northwestern Medicine study.
A novel combination treatment may increase the ability of monoclonal antibodies to control viral infection in patients diagnosed with HIV, according to a Northwestern Medicine study.
Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.
Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
A recent campus talk explored how clinical trials of HIV/AIDS drugs in developing countries in the 90s sparked a wealth of discussions about ethics in scientific investigation and barriers to healthcare access.
In partnership with the AIDS Foundation of Chicago and several Northwestern University Feinberg School of Medicine departments and centers, the Public Health Boot Camp delivers an annual week-long residential training program for HIV/AIDS community-based service providers.
Robert Riestenberg, a third-year medical student, was the first author of a recent study that evaluated statin use among people with HIV, a population at an increased risk for cardiovascular disease.
Northwestern scientists specializing in HIV and AIDS gathered to share their experiences during a panel held December 3, to commemorate World AIDS Day.